ViroPharma Europe is ViroPharma's wholly-owned European subsidiary, which commenced in 2007 to leverage in Europe the company's expertise in the development and commercialization of biotechnology products, and in business development. ViroPharma seeks to acquire opportunities in areas of strategic interest to the company; Our strategy is to target serious diseases by building franchises within narrowly focused prescribing groups, with an initial niche focus on C1 esterase inhibitor deficiency and seizures in children and adolescents. Our interest could expand into other areas if they are compatible with our general business plan (i.e. niche opportunities, supportable by specialty marketing).

European Headquarters
ViroPharma SPRL - BVBA
rue Montoyer 47
1000 Brussels
Belgium
Tel: +32 (0)2 747 0971
Fax: +32 (0)2 706 2421